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Abstract The neuropathological hallmarks of Alzheimer’s
disease (AD) include the presence of extracellular
amyloid-β peptide (Aβ) in the form of amyloid plaques and
neuronal loss. Neural stem cell (NSC) is being scrutinized as a
promising cell replacement therapy for various neurodegener-
ative diseases. However, the unfavorable niche at the site of
degenerative disease is hostile to the survival and differentia-
tion of transplanted cells. Here, we undertook in vitro and
in vivo works to examine whether a designer self-assemble
peptide (DSP), which contains one functional domain Tyr-Ile-
Gly-Ser-Arg (YIGSR) derived from laminin, promotes the
survival and neuronal differentiation of NSC and behavioral
improvement. We found that DSP could undergo spontaneous
assembly into well-ordered nanofibers, and it not only facili-
tated the cell viability in normal culture condition, but also
decreased the number of apoptotic cells induced by Aβ
in vitro. NSC seeded in DSP showed much more neuronal
differentiation than that seeded in self-assemble peptide (SP)
or alone. In the AD model, NSC transplantation in DSP-
treated AD rats demonstrated much more obvious cognitive
rescue with restoration of learning/memory function com-
pared with NSC transplantation in SP, NSC alone, or DSP
alone treated ones. Interestingly, DSP enhanced the survival
and neuronal differentiation of transplanted NSC. Apoptosis
levels in the CA1 region and Aβ level in the hippocampus
were significantly decreased in the group of NSC transplanta-
tion in DSP. Moreover, synaptic function, indicated by the
expression of pre-synaptic protein synapsin-1, was restored
and the secretion of anti-inflammatory and neurotrophic fac-
tors were increased, such as IL-10, brain-derived neurotrophic
factor (BDNF), ciliary neurotrophic factor (CNTF), and
insulin-like growth factor 1 (IGF-1), while the expression of
pro-inflammatory factors were decreased, such as TNF-α and
IL-1β. These data firstly unveiled that the biomaterial DSP
can maximize the therapeutic benefits of NSC transplantation
for AD through improving the survival and differentiation of
transplanted stem cells and promoting the effects of neuropro-
tection, anti-neuroinflammatory and paracrine action. Our re-
sults may have important clinical implications for the design
of future NSC-based strategies using the biomaterials for var-
ious neurodegenerative diseases including AD.
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Introduction
Alzheimer’s disease (AD) accounts for more than 60 % of all
dementias and the prevalence of AD expected to increase
dramatically as the life expectancy and aging population rise
worldwide [1]. AD involves a progressive decline in mental
function, usually including learning and memory deficits, lan-
guage difficulties, daily activities impairment, and other cog-
nitive processes. The neuropathology is characterized by ex-
tracellular deposition of amyloid-β peptide (Aβ)-containing
senile plaques, the intracellular presence of numerous neuro-
fibrillary tangles, and selective loss of neurons [2]. The amy-
loid cascade hypothesis suggesting a pivotal role for Aβ in the
pathogenesis of AD is the mechanism that is accepted by most
researchers in this field [3]. The peptide with 40 or 42 amino
acids has been shown in numerous studies to be toxic to neu-
ron and thought to be responsible for neuronal and synaptic
loss, leading to progressive cognitive decline in patients with
AD [4–6]. Current approved therapies, including acetylcho-
linesterase inhibitors and glutamate inhibitors offer only mar-
ginal benefits and do not compensate for the massive and
progressive neuronal and synaptic loss in the cortex and hip-
pocampus [7, 8]. Besides, in animal models of AD,
neurogenesis has been shown to be impaired, which resulted
in a loss of neuron gradually with limited recruitment [9].
Thus, one possible treatment strategy for AD would be to
prevent and/or replace neurons lost during the disease process.
Neural stem cell (NSC) has the potential for self-renewal
and ismultipotent cell that is capable of generating the main
cell phenotypes of the central nervous system, including neu-
rons, astrocytes, and oligodendrocytes. Thus, it has been sug-
gested that NSCs are capable of compensating for lost or
damaged neurons in many neurological diseases. NSC trans-
plantation has been tested as a potential treatment of neuro-
logical disorders, including traumatic brain injury, stroke, is-
chemia, and neurodegenerative disorders [10–12]. With re-
spect to AD, studies have shown that NSC transplantation
improved the cognitive ability of a transgenic model of AD
via increasing brain-derived neurotrophic factor (BDNF) [13].
The most recent report found that NSC transplantation could
not only replace the damaged or lost neurons resulting from
Aβ plaque but also be helpful to establish new synaptic con-
nectivity to improve cognitive dysfunction [14].
Although NSC transplantation is a potential approach for
AD, the sustained survival and neuronal differentiation of ex-
ogenously transplanted NSCs, as well as their functional inte-
gration into host neuronal circuitry, remain a major challenge
[15]. The pathological environment, especially the presence of
aggregated Aβ peptide in AD brains has a negative effect on
the survival, migration, and differentiation of both endoge-
nous and exogenous NSC [16]. Aβ peptide has differential
effects on the human embryonic stem cell proliferation de-
pending on its aggregation level [17, 18]. The viability of
NSC treated with Aβ25–35 oligomers was significantly de-
creased in a concentration-dependent manner [19]. Thus, de-
velopment of clinically relevant and feasible strategies that
can enhance proliferation, survival, neuronal differentiation,
and functional integration of transplanted NSCs into neuronal
networks of the host’s brain is urgently required if exogenous-
ly transplanted NSCs are to be utilized as a clinically effective
therapeutic approach to neurodegenerative disorders includ-
ing AD.
Attempts have been made to incorporate cells into bioma-
terials that might help restore a three-dimensional environ-
ment facilitating cell survival, proliferation, and differentia-
tion. An ideal biomaterial should be fabricated from a synthet-
ic biological material with defined constituents. Self-
assembling peptide RADA16 consist of alternating hydrophil-
ic and hydrophobic amino acids and could form a nanofiber
scaffold under physiological conditions [20]. The scaffolds
can support neuronal cell attachment and differentiation as
well as extensive neurite outgrowth. Furthermore, they are
permissive substrates for functional synapse formation be-
tween the attached neurons [21].Materials functionalizedwith
laminin or laminin-derived peptides have been shown to in-
crease neurite extension [22], and influence cellular attach-
ment, migration, proliferation, and differentiation [23, 24],
which indicates that it is promising as an extracellular matrix
platform for regeneration. Tyr-Ile-Gly-Ser-Arg (YIGSR) is a
laminin-derived motif and was beneficial to promote cell at-
tachment and laminin receptor binding [25]. YIGSR-
functionalized matrices have been found to improve the
neurite sprouting and regeneration. Moreover, matrices mod-
ified with YIGSR have shown similar or superior biologic
effects to another laminin-derived bioactive peptide Ile-Lys-
Val-Ala-Val (IKVAV) and laminin-coated matrices [26, 27].
Based on these findings, we further investigated the poten-
tial therapeutic effects of YIGSR-functionalized self-assemble
peptide RADA16 in a rat model of AD generated by Aβ
injection. The primary goal of the study is to test the potential
utility of a designer self-assemble peptide (DSP) with func-
tional domain YIGSR to promote the survival and
neurogenesis of NSC transplanted into the hippocampus,
and further to estimate its advantage to reduce hippocampus
neuronal apoptosis and Aβ level, and to enhance the synaptic
function and paracrine action, thereby facilitating the clinical
use of NSC transplantation for the treatment of a number of
neurodegenerative diseases including AD.
Materials and Methods
The animals were randomly assigned and raised on a 12-h
light/dark cycle at constant temperature, with free access to
food and water. The study was approved by the Shanghai
Ethics Committee and all animal procedures were performed
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in accordance with the National Institutes of Health Guide for
the Care and Use of Laboratory Animals. We made every
effort to minimize both the number of animals used and ani-
mal suffering.
Designer Peptide Synthesis and Atomic Force Microscopy
Observation
To get the functionalized peptide, we modified the self-
assembling peptide RADA16 (Ac-RADARADARADA
RADA-CONH2) with a bioactive motif YIGSR, derived from
laminin. Two glycine residues were added, between the as-
sembling portion of the peptides and the functional motifs, for
flexibility. The sequence of DSP is: Ac-(RADA)4GGYIGSR-
CONH2. The DSP and RADA16 (self-assemble peptide, SP)
were custom-synthesized. They were dissolved in distilled
sterile water at a final concentration of 1 % (w/v) (10 mg/
mL) and sonicated for 30 min before use. The structures of
the peptides were observed under atomic force microscopy
(AFM) using a tapping mode. Peptide from stock solutions
(1 %) was diluted to a working concentration of 0.01 % (w/v)
with distilled sterile water. After sonication for 30 min, 1-μL
sample was loaded onto a freshly cleaved mica surface. To
optimize the amount of peptide adsorbed, each aliquot was left
on mica for 60 s and then washed with 100 μL of deionized
water at least three times. The mica surface with the adsorbed
peptide was then air-dried and imaged immediately. Images
with a resolution of 512×512 pixels were obtained by an
AFM microscope (Nanoscope-MultiMode/Dimension,
Digital Instruments, Santa Barbara, CA) running in a tapping
mode. Typical scanning parameters were as follows: tapping
frequency 75 KHz, RMS amplitude before engage 1–1.2 V,
set point 0.7–0.9 V, integral and proportional gains of 0.2–0.6
and 0.4–1.0, respectively, and scan rate of 1.51 Hz.
Neural Stem Cell Isolation and Culture
NSCs were isolated directly from the hippocampus of postna-
tal day 1 male Sprague-Dawley (SD) rats. Gender of rats was
determined by real-time polymerase chain reaction (RT-PCR)
with rat sex-determining Region Y (SRY) primers according
to the protocols published byMüller-Ehmsen et al. [28]. After
being dissociated mechanically, the cells were harvested by
centrifugation and resuspended in Neurobasal medium
(Gibco, CA, USA) containing B-27 supplement (2 %,
Gibco, USA), 20 ng/mL basic fibroblast growth factor
(bFGF, PeproTech, USA), 10 ng/mL epidermal growth factor
(EGF, PeproTech, USA), penicillin (50 U/mL), and strepto-
mycin (50 μg/mL). The cells were adjusted to a density of 1×
105 cells/mL and planted in culture dishes. A half of culture
medium was changed every 3 days. An aggregate form of
NSCs, which were named neurospheres, were observed dur-
ing this procedure at about day 7. Then, neurospheres were
collected, dissociated with Accutase (Sigma, USA) for 5 min,
and passaged at a cell density of 1×105 cells/mL. Cell
counting and viability examination is required at every pas-
sage, using trypan-blue exclusion method. The five passages
of NSC were used for the in vitro and in vivo experiments.
Immunocytochemistry Staining
For cell seeding in peptides, 30μL peptide solution was added
to evenly cover the bottom surface of each well of 96 multi-
well plates (BD Biosciences), followed by slow addition of
200 μL/well of medium containing NSC at a density of 2×
105 cells/mL. At 2 weeks after being seeded, cultured cells in
the group of NSC seeded in DSP (DSP group), NSC seeded in
SP (SP group), and NSC alone (control group) were washed
briefly with phosphate-buffered saline (PBS) and then fixed
with 4 % paraformaldehyde for 20 min, subsequently incubat-
ed with blocking solution (10% goat serum in PBS containing
0.1 % Triton-X100) for 1 h at room temperature. Neuronal
differentiation was determined by immunostaining with anti-
neuron specific enolase (NSE) (1:200, Abcam, USA) diluted
in blocking solution overnight at 4 °C. Goat-raised secondary
antibodies were incubated 1 h at room temperature. Cell nuclei
were stained with 4 ,6-diamidino-2-phenylindole
(DAPI;1:1000; Sigma, USA) in PBS for 5 min. Negative con-
trols for immunostaining were also performed.
RT-PCR Analysis
NSCs were harvested and total RNA was extracted with
TRIzol (Roche). The synthesis of the first-strand complemen-
tary DNA (cDNA) was carried out from 1 μg of total RNA
using reverse transcriptase (Takala) according to the manufac-
turer’s instructions. After synthesis, cDNA was used in PCR
reaction with gene-specific primers. The sequences of the
PCR primer pairs (5′ to 3′) that were used for each gene are
as follows: nestin, GGAGTGTCGCTTAGAGGTGC
(forward) and CAGCAGAGTCCTGTATGTAGCC
(reverse); β3-tubulin (Tuj1), TGCGTGTGTACAGGTGAA
TGC (forward) and AGGCTGCATAGTCATTTCCAAG
(reverse); NSE, GTGGACCACATCAACAGCAC (forward)
and TGAGCAATGTGGCGATAGAG (reverse); and glial fi-
brillary acidic protein (GFAP), CTCAATGCTGGCTTCAAG
GAGA (forward) and GACGCAGCGTCTGTGAGGTC (re-
verse). In addition, amplification of β-actin from the same
amount of cDNA was used as an endogenous control with
the following primers: forward CAATGAGCGGTTCCGA
TG, reverse GCCACAGGATTCCATACCCA. Products were
analyzed on agarose gel and visualized by ethidium bromide
staining. The relative amount of each transcript was normal-
ized to the level of β-actin.
1110 Mol Neurobiol (2016) 53:1108–1123
MTS Assay
Aβ1–40 was dissolved initially in sterile, distilled water and
further diluted with 0.1 M PBS without calcium. The solution
of Aβ1–40 was incubated for 5 days at 37 °C to allow fibril
formation. Aliquots were stored at −80 °C until use. For
in vitro cytotoxicity of Aβ1–40 on NSC, the Cell Titer 96
AQueous One Solution Cell Proliferation Assay (Promega,
France) was tested. NSC were plated at 10,000 cells/well in
a 96-well plate in the absence and presence of Aβ1–40 (Sigma;
1, 5, 10, 20, 40 μM) in a 96-well plate. According to the
manufacturer’s recommendations, 20 μL MTS solution was
added into each of the wells at day 2 of cell culture. Then, cells
were incubated for 2 h at 37 °C in the humidified 5%CO2 atm
incubator, and results were obtained at a wavelength of
490 nm. The same volume of medium without cells was used
as blank. Results were expressed in optical density (OD).
Cell Viability in DSP with or Without Aβ Treatment In Vitro
After seeding NSC within the DSP, the cell viability was ob-
served using a fluorescence microscope by acridine orange/
ethidium bromide (AO/EB) staining at 7 and 14 days. The
fluorescence dye AO/EB was added to the supernatant. Both
AO and EB were at the concentration of 100 μg/mL in PBS.
The number of different stained cells was determined by
counting 300 cells at five random, non-overlapping fields in
five different cell samples. Data were expressed as percentage
of survived cells in each group. To further test the neuropro-
tective effect of DSP on NSC, the cells were simultaneously
treated with 40 μMAβ1–40. Then, the morphological changes
of the cells were observed by dual staining of propidium io-
dide (PI) and DNA-binding fluorochrome Hoechst 33342.
Apoptosis was observed by Hoechst 33342, characterized by
chromatin condensation and nuclear fragmentation, while in
the event of late apoptosis and necrosis, loss of membrane
integrity could be detected by PI.
Intra-hippocampally Injected Aβ1–40 Rat Model and NSC
Transplantation
Animals were randomly assigned to seven experimental
groups each comprising 15 SD female rats: the groups of
normal, control, NSC, SP, NSC + SP, DSP, and NSC + DSP.
All of the rats, except in the normal group, were anesthetized
by intraperitoneal injection of sodium pentobarbital
(50 mg/kg), and placed into a stereotaxic instrument (David
Kopf instruments, USA). An incision was made along the
midline, and the area surrounding the bregma was cleaned
and dried. Aβ1–40 solutions (2.5 μg/μL) were administrated
by injections with a Hamilton microsyringe fixed to a 26-
gauge needle. Two microliters of Aβ1–40 were administered
over 5 min into the CA1 area of hippocampus at coordinates
incisor bar −3.3 mm, 3.8 mm posterior to the bregma,
±3.2 mm lateral to the sagittal suture, and 2.7 mm down from
top of the skull bilaterally [29]. The needle remained in posi-
tion for an additional 5 min after injection to allow diffusion
into the surrounding tissue. After that, transplantation of pep-
tides, or NSC at passage 5 (5×105, 5 μL, 1 μL/min) derived
from male rats with or without peptides was performed with a
new microsyringe. Injection coordinates for the hippocampus
were the same as the Aβ injection. In the NSC group, NSC
was suspended in 5 μL of PBS and the cell suspension was
injected. In peptides alone and control groups, SP or DSP was
dissolved in sterile sucrose (295 mmol/L) at 1 % (w/v) and
sonicated for 20 min, 5 μL of SP or DSP and PBS was
injected, respectively. In the group of NSC in peptides, NSC
were suspended in 5 μL of peptides solution and then injected.
After injection, the syringe was left in place for an additional
5 min before it was slowly withdrawn. The incision was
closed after and the animal was allowed to recover under a
heat lamp. Chloramphenicol (1 % solution) was applied to the
exposed skull and scalp before closure to limit local infection.
Morris Water Maze Test
Four weeks after the transplantation, the training of all exper-
imental groups of animals started in the Morris water maze.
This maze included a black-painted circular water tank (150-
cm diameter, 60-cm height), filled to a depth of 40 cm with
water (22±2 °C). This pool was divided to four equal-spaced
quadrants and a hidden transparent platform (10 cm in diam-
eter), made of Plexiglas was located 1 cm below the surface of
the water in the center of the north-west quadrant (target quad-
rant). The task was conducted twice a day for 5 consecutive
days. In each trial, the rat was placed in the water at one of four
starting positions, with the sequence of the positions being
selected randomly. Animals were allowed to swim in the pool
during a period of 70 s and find the hidden platform. If an
animal did not find the platform within this period, it was
manually guided to the platform by the researcher. The rats
rested 30 s between two consecutive trials and all trials at
about the same time of the morning were performed.
Directions of the rats were recorded by a video camera located
just above the center of the maze. The camera was linked to a
computer. Learning capabilities were tested by measuring es-
cape latency (time to find the platform), and swimming speed
parameters. For measurement of post-training probe trial tests,
animals were trained for 5 days as described above, and on the
next day, post-training probe trial tests were performed. In the
probe trial test, the hidden platformwas removed, and animals
were placed in the pool in the opposite of the target quadrant
and allowed to swim freely for 70 s. The occupancy and
crossing of animals in proximity of the target quadrant (the
quadrant included the hidden platform during training trials)
were assessed.
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Fluorescence In Situ Hybridization
and Immunohistochemistry Staining
After being fixed with 4 % paraformaldehyde and
dehydrated in 30 % sucrose-containing PBS, the tissues
were then embedded in OCT (Fisher Scientific) and
rapidly frozen in −80 °C. Coronal sections (20 μm)
through the hippocampus were cut on a cryostat (Leica
CM 3050, Deerfield, IL). For detecting the existence of
the transplanted NSC, in situ hybridization using rat Y
chromosome specific gene was performed as we de-
scribed before [30]. To determine the differentiation of
transplanted cells, immunohistochemistry for Tuj-1 was
performed. The same sections were incubated with
mouse monoclonal Tuj-1 antibody (1:200; Abcam) over-
night at 4 °C. Synapsin-1 was also detected with rabbit
anti-synapsin-1 (1:100, CST). The sections were then
incubated with donkey anti-mouse or anti-rabbit anti-
body (Jackson, USA) for 2 h at room temperature.
After washing, the nuclei were counterstained with
DAPI. The neuronal apoptosis was estimated by the
staining of Hoechst 33342 and the number of apoptotic
cells was counted under ×200 fields.
Western Blot Analysis
Hippocampus tissue from each group was homogenized in
ice-cold radio-immunoprecipitation assay (RIPA) lysis buffer
containing protease inhibitor phenylmethylsulfonylfluoride
(PMSF) with a glass homogenizer on ice. The lysates were
centrifuged at 12,000 rpm for 5 min. The supernatant was
collected and protein concentration was measured using a
BCA protein assay kit (Pierce, Rockford, IL). After boiling
for 5 min, an equal amount of total protein (30 or 50 μg each)
was separated on 10 or 15 % sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS-PAGE) and then trans-
ferred onto a polyvinylidene fluoride (PVDF) membrane
(Millipore, USA). Membranes were blocked for 1 h at room
temperature with 5 % (w/v) nonfat dried milk in Tris-buffered
saline Tween-20 (TBST), and incubated with specific primary
antibodies against phosphorylated Akt (p-Akt; Ser473;
1:500), Akt (1:1000), caspase-3 (1:2000), cleaved caspase-3
(1:1000), Bcl-2 (1:500), Bax (1:500), and synapsin-1 (1:1000;
all from Cell Signaling Technology) overnight at 4 °C.
Antibody binding was revealed by incubation with horserad-
ish peroxidase-conjugated anti-mouse or anti-rabbit antibod-
ies (1:5000–10,000; Jackson, USA). Enhanced chemilumi-
nescence (ECL) was detected by exposure to x-ray film, with
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Cell
Signaling Technology) used as an internal control.
Densitometric analysis of the bands was performed with an
image analyzer (Quantity One v4.62, Bio-Rad).
ELISA
To evaluate the presence and degradation of the injected Aβ,
hippocampus and cortex tissues were homogenized in 10 vol-
umes of lysis buffer with protease inhibitor mixture
(Complete, Mini, EDTA-free, Roche). After centrifugation at
10,000×g for 15min at 4 °C, supernatants were assessed using
the human Aβ1–40 enzyme-linked immunosorbent assay
(ELISA) kit (Immuno-Biological Laboratories, Japan). In
brief, 100 μL of sample was added into the precoated 96-
well assay plate and incubated overnight at 4 °C. Then, the
wells were washed three times and 100 μL of labeled antibody
solution was added to each well for 1 h at 4 °C in the dark.
After washing with three times, 100 μL of chromogen solu-
tionwas added. The samples were gentlymixed and incubated
for 15 min at 37 °C in the dark. Then, 50 μL of stop solution
was added into each well and the absorbance was examined at
450 nm with a microplate reader (Bio-Rad, USA) within
15 min. The expression of BDNF, ciliary neurotrophic factor
(CNTF), insulin-like growth factor 1 (IGF-1), TNF-α, IL-1β,
and IL-10 was also detected through the specific ELISA kit.
Quantitative Real-Time PCR
Four weeks after transplantation, rats were killed and hippo-
campal tissues were extracted and homogenized on ice imme-
diately. Subsequently, total RNA was extracted from each
sample TRIzol reagent according to the manufacturer’s pro-
cedures, and the concentration was assessed using a
NanoDrop ND-1000 spectrophotometer (Thermo Scientific,
USA). A total of 1 μg of each template RNA was converted
to the first strand of cDNA. The survival of transplanted NSC
was determined by the expression of SRY through PCR as
previously described. Real-time PCR of cDNAwas performed
(ABI PRISM 7500 Sequence Detection System, Applied
Biosystems) using SYBR Green ready mix (Applied
Biosystems) and the forward and reverse primer. The primers
for each gene were: BDNF, forward TCTACGAGACCAAG
TGTAATCC, reverse TATGAACCGCCAGCCAAT; ciliary
neurotrophic factor (CNTF), forward AAACACCTCTGA
CCCTTCAC, reverse AGTCATCTCACTCCAACGAT;
insulin-like growth factor 1 (IGF-1), forward CTGGCACT
CTGCTTGCTCAC, reverse CTCATCCACAATGCCCGT
CT; TNF-α, forward GCCCACGTCGTAGCAA, reverse
GTCTTTGAGATCCATGCCAT; IL-1β, forward GAGCTG
AAAGCTCTCCACCT, reverse TTCCATCTTCTTCTTTGG
GT; IL-10, forward CAGAAATCAAGGAGCATTTG, re-
verse CTGCTCCACTGCCTTGCTTT; and glyceraldehyde-
3-phosphate dehydrogenase (GAPDH), forward GGAAAG
CTGTGGCGTGAT, reverse AAGGTGGAAGAATGGGAG
TT. GAPDH was used as an endogenous control to normalize
expression levels. Real-time PCR data was analyzed using
comparative critical threshold (Ct), and the relative expression
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levels were calculated according to the formula: 2−ΔΔCt [31].
The specificity was verified by melt curve analysis and aga-
rose gel electrophoresis.
Statistical Analysis
Data are expressed as themeans±standard deviation. To analyze
the data statistically, we performed one-way analysis of variance
(ANOVA) with S-N-K post hoc multiple comparison analysis.
Avalue of P<0.05 was considered to be statistically significant.
Results
Structures of Designer Self-Assembling Peptide
There was concern that the incorporation of appendedmotif to
the RADA16 peptide would prevent peptide self-assembly.
Thus, we used AFM to examine the nanofiber structures of
the designer peptide to address this concern. AFM images
demonstrated that RADA16 can undergo spontaneous assem-
bly into well-ordered nanofibers in the presence of solutions
that contain monovalent salts. Meanwhile, nanofibers ~10 nm
in fiber diameter could be fabricated by the spontaneous self-
assembly of the designer peptide introduced to physiological
salt-containing solutions (Fig. 1a, b). It was evident that the
appended functional motif did not inhibit the self-assembling
peptide nanofiber formation.
Designer Self-Assemble Peptide was Beneficial
to the Differentiation of NSC
The differentiation of NSC toward neuron was detected
through immunocytochemistry and RT-PCR to estimate the
effect of functional motif-modified self-assembling peptide
in vitro. According to the results of immunocytochemistry,
most of the cells in DSP apparently expressed NSE, one of
the glycolytic enzymes distributed exclusively in neurons
(Fig. 2a). RT-PCR demonstrated that the expression of nestin,
a widely employed marker of multipotent NSC, was much
lower in the DSP group at 2 weeks after being seeded than that
in the SP or control group, indicating that much more NSC has
differentiated to others cells. Interestingly, the cells seeded in
DSP expressed more Tuj-1 and NSE than other groups, which
demonstrated that neuronal differentiation was facilitated
through YIGSR modification of RADA16. Compared with
the SP and control groups, less cells in the DSP group
expressed the astrocyte marker GFAP, although there were
no significant differences among the three groups (Fig. 2b, c).
DSP Promotes Cell Survival Under Normal Condition
and Aβ Treatment
The AO/EB double staining was performed to analyses cell
survival in DSP at 7 and 14 days after being seeded. At both
time points, the highest percentage of living cells was observed
in the functionalized peptide containing the YIGSR functional
motif, which suggests that this amino acid sequence may be
important to support NSC viability (Fig. 3a). The MTS assay
was used to determine Aβ1–40-induced toxicity (Fig. S1). A 24-
h exposure to Aβ1–40 induced a toxic, dose-dependent effect on
NSC, with a maximal effect of ~60 % noted at a concentration
of 40μM. Thus, 40μMwas used as the concentration for Aβ1–
40 to test the neuroprotective effect of DSP on NSC. After
treatment with Aβ, most of NSC displayed apparent morpho-
logical changes of necrosis and apoptosis in the control group
by PI/Hoechst 33342 double staining. Although in the presence
of SP, there were many necrotic and apoptotic cells observed.
However, the necrosis and apoptosis of NSC was obviously
suppressed in the DSP group (Fig. 3b). The number of necrotic
and apoptotic cells were both significantly decreased compared
with that in the control and SP groups (Fig. 3c).
NSC Transplantation in Designer SP Rescued Behavioral
Impairment
The effects of NSC transplantation in DSP on learning and
memory ability in rats exposed to Aβ1–40 were assessed using
Fig. 1 Tapping mode AFM
images of peptides RADA16 (a)
and RADA16 modified with
YIGSR (b). The appended
functional motif did not prevent
peptide self-assembly
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the Morris water maze test described above. Spatial learning
was measured as escape latencies per day. In the place naviga-
tion trials, compared with normal group, the escape latency was
obviously increased (days 2~5) in Aβ1–40 treated rats. Rats in
all of the treat groups displayed significantly shorter latencies
than those of the model rats on days 3~6 of training, indicating
improvements in spatial acquisition. Compared with the NSC
group, NSC transplantation in SP could decrease the escape
Fig. 2 Designer self-assemble
peptide was conducive to the
differentiation of NSC in vitro. a
The differentiation of NSC in
DSP toward to neuron was
detected by NSE
immunocytochemistry staining.
Scale bar 100 μm. b PR-PCR
showed the expression of
different genes 2 weeks after
being seeded in each group. c
Quantitative analysis of the genes
expression. *P<0.01 and
$P<0.05 versus control; #P<0.05
versus SP
Fig. 3 Designer self-assemble peptide increased the cell viability and
protected NSC to against the cytotoxicity of aggregated Aβ. a Cell via-
bility was detected byAO/EB staining at 7 and 14 days after being seeded
in DSP. NSC in modified peptides showed increased cell survival com-
pared to the unmodified RADA16. *P<0.01 versus control; #P<0.01 and
$P<0.05 versus SP. b, c Cell survival after Aβ1–40 treatment. PI/Hoechst
33342 staining demonstrated that DSP decreased the number of apoptotic
NSC compared to the unmodified SP, suggesting more efficient to against
the neurotoxic of Aβ. White arrow indicated PI-positive cells and
arrowhead indicated Hoechst 33342-positive cells. Scale bar 20 μm.
*P<0.05 and **P<0.01 versus control; #P<0.05 versus SP
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latency significantly in days 4 and 5. However, rats in the group
of NSC transplantation in DSP had the shortest latency among
the treated groups. From day 3, there was a remarkable differ-
ence between the group of NSC transplantation in DSP and
NSC transplantation in SP (Fig. 4a). Swimming speed was
not significantly different between groups during the 5 days
(Fig. 4b). In the spatial probe trials, NSC transplantation effec-
tively increased the time spent in the target quadrant and num-
ber of platform location crosses, indicating impaired spatial
memory recall. Although SP could facilitate the efficiency of
NSC transplantation, no apparent difference was observed be-
tween NSC and NSC in SP group. However, rats received NSC
transplantation in DSP remained in the original platform quad-
rant longer and crossed the former quadrant containing the
platform more frequently compared to NSC carried in SP-
treated rats, suggesting NSC injection in DSP exerted much
more efficient improvement in behavior recovery (Fig. 4c, d).
DSP Promoted the Survival and Neuronal Differentiation
of Transplanted NSC
The survival of transplanted NSC derived from male rats was
monitored by using the SRY gene, which triggers embryonic
development as a male in mammals. RT-PCR for the SRY
gene using hippocampus tissue from NSC transplantation
groups with peptides demonstrated that both peptides could
be conducive to the expression of SRY (Fig. 5a).
Expression of SRY in the group of NSC in SP was higher
than that in the NSC group. Moreover, NSC transplanta-
tion in DSP showed much more SRY genes compared
with the group of NSC in SP, which indicated that NSC
transplanted within DSP represented the highest survival
rate (Fig. 5b). Expressions of Tuj-1 and Y chromosome
in CA1 region were detected by immunohistochemical
staining to estimate the differentiation of NSC toward neu-
ron in vivo (Fig. 5c). There were much more Y
chromosome-positive cells in the group of NSC in DSP
than that in the group of NSC in SP, which also demon-
strated the best survival rate in the group of NSC in DSP.
SP could contribute to the expression of Tuj-1 in Y
chromosome-positive cells. Interestingly, a significantly
higher fraction of Y chromosome-positive cells were la-
beled by Tuj-1 in the group of NSC in DSP than that
in the group of NSC in SP, suggesting that neuronal dif-
ferentiation of transplanted NSC may be facilitated
through the addition of functional motif to SP (Fig. 5d).
Fig. 4 Inhibitory effects of NSC transplantation in DSP on memory
impairment in Aβ1–40-infused rats model. a NSC transplantation in
DSP improved spatial learning in AD rats. From day 3, there was a
remarkable difference between the group of NSC transplantation in
DSP and NSC transplantation in SP. Spatial learning was measured as
escape latencies per day. b Swimming speed was not significantly
different between groups. c, d NSC transplantation in DSP-restored spa-
tial memory in the AD rats. Rats spatial memory was evaluated by the
number of time spent in the target quadrant and platform location crosses.
There was no apparent difference was observed between NSC and NSC
in SP group. However, rats received NSC transplantation in DSP
remained in the original platform quadrant longer and crossed the former
quadrant containing the platform more frequently compared to NSC car-
ried in SP-treated rats. *P<0.01 versus normal, #P<0.01 versus control,
$P<0.05 versus NSC, &P<0.05, and &&P<0.01 versus NSC + SP
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NSC Transplantation in DSP Prevented the Apoptosis
Induced by Aβ
We explored whether NSC transplantation in DSP was able to
improve memory impairment by preventing Aβ1–40 induced
neuronal cell death in the hippocampus. Apoptosis was de-
tected through Hoechst 33342 staining. The apoptotic nucleus
appears smaller, condensed, and deeply stained. The results
showed that there were few apoptotic neurons in the normal
group, while in the control group, the apoptotic cells signifi-
cantly increased. Compared with the control group, all of the
treatments significantly alleviated the apoptotic cells in the
hippocampus CA1 region, especially in the groups of NSC
in SP and NSC in DSP (Fig. 6a). Although SP decreased the
number of apoptotic cells, the difference of neuronal apoptosis
between the groups of NSC and NSC in SP was indistinguish-
able. The number of apoptotic cells in the group of NSC in
DSP was much less than that in the groups of NSC in SP and
DSP (Fig. 6b). Moreover, the expression of cleaved caspase 3
and p-Akt, known to be involved in the process of apoptosis,
were examined by Western blot in hippocampus tissue. The
control group represented the highest cleaved caspase 3 and
lowest p-Akt level. NSC transplantation alone or in SP could
downregulate the expression of cleaved caspase 3 and upreg-
ulate the expression of p-Akt. Expression of p-Akt appeared
with significant difference between the group of NSC and
NSC in SP, while no statistic difference in the expression of
cleaved caspase-3. However, cleaved caspase 3 was lower and
p-Akt was higher in the group of NSC in DSP than that in the
group of NSC in SP. There was no significant difference in
Fig. 5 DSP promoted the survival and neuronal differentiation of
transplanted NSC. a RT-PCR for the SRY gene using hippocampus tissue
fromNSC transplantation groups with or without peptides. bQuantitative
analysis of SRY gene expression. *P<0.01 versus NSC, #P<0.05 versus
NSC + SP. c Expression of Tuj-1 by Y chromosome-positive cells. Much
more Y chromosome-positive cells in CA1 regions co-expressed Tuj-1
than that in NSC and NSC + SP groups. Scale bar 50 μm. d Quantitative
analysis of the percentage of Tuj-1 and Y chromosome double positive
cells in all of the Y chromosome-positive cells. *P<0.01 versus NSC, and
#P<0.01 versus NSC + SP
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caspase-3 expression among the groups. The expression of the
proteins involved on caspase regulation was further detected.
NSC transplantation increased the level of Bcl-2 and de-
creased the level of Bax. Samples from the group of NSC +
DSP exhibited much higher level of Bcl-2 than the group of
NSC + SP. These data indicated that NSC transplantation in
DSP prevented the apoptosis induced by Aβ in hippocampus
tissue through contributing to the upregulation of p-Akt,
downregulation of cleaved caspase 3 and then balancing the
ratio of Bcl-2 to Bax (Fig. 6c–g).
Fig. 6 NSC transplantation in DSP prevented the apoptosis induced by
Aβ in hippocampus tissue through upregulation of p-Akt,
downregulation of cleaved caspase 3 and balancing the ratio of Bcl-2 to
Bax. a Apoptosis was detected through Hoechst 33342 staining in CA1
region. White arrow indicated Hoechst 33342-positive cells. Scale bar
30 μm. bQuantitative analysis of Hoechst 33342-positive cells. *P<0.01
versus control, #P<0.01 versus NSC + SP, $P<0.01 versus DSP. c Ex-
pression of p-Akt, cleaved caspase 3, Bcl-2 and Bax in hippocampus
tissue examined byWestern blot. d–gQuantitative analysis of the expres-
sion of p-Akt, cleaved caspase 3, Bcl-2, and Bax. *P<0.01 versus control,
#P<0.05 and ##P<0.01 versus NSC + SP, $P<0.01 versus DSP, and
&P<0.05 versus NSC
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NSC Transplantation in DSP was Beneficial to the Recovery
of Synaptic Function
Synaptic proteins are important for the normal functioning of
synapses. We further investigated the expression of pre-
synaptic protein synapsin-1 in hippocampus by immunohisto-
chemistry staining and western blot (Fig. 7a, b).We found that
the level of synapsin-1 was markedly reduced in the Aβ-
treated rats. The level of synapsin-1 in the hippocampus was
markedly elevated in the groups of NSC, NSC in SP, DSP, and
NSC in DSP, but not in the SP group. Interestingly, DSP
injection alone was beneficial to the restoration of synaptic
function, and represented more advantage than SP transplan-
tation. There was no significant difference between the groups
of NSC alone and DSP alone. More importantly, NSC trans-
plantation in DSP increased the expression of synapsin-1 in
the most extent compared with other groups (Fig. 7c).
Inhibitory Effect of NSC Transplantation in DSP on Aβ1–40
Aβ1–40 level in rat hippocampus tissue and cortex was mea-
sured by ELISA to examine the inhibitory effect of NSC trans-
plantation in DSP on Aβ1–40. As shown in Fig. 8a, although
Aβ could be degraded in some extent by the endogenous
enzymes, Aβ1–40 level in hippocampus tissue was very high
in the control group. NSC transplantation with or without
peptides obviously attenuated the Aβ1–40 level in hippocam-
pus tissue. The expression of Aβ1–40 in the group of NSC in
SP was similar to the NSC group, indicating that SP couldn’t
play a potential synergistic effect with NSC on downregula-
tion of Aβ in hippocampus tissue. NSC transplantation in
DSP showed the lowest Aβ1–40 level among all of the treated
groups, and there were significant differences between the
groups of NSC in DSP and DSP alone or NSC in SP.
However, Aβ1–40 level in cortex was no significant differ-
ences among all of the groups including normal and control
groups (Fig. 8b).
Determination of Neurotrophin and Inflammatory Cytokines
RNA Levels
Themessenger RNA (mRNA) expression of neurotrophin and
inflammatory cytokines in each group at 4 weeks after trans-
plantation was detected by quantitative real-time PCR. The
expression of neurotrophin cytokines was significantly in-
creased after NSC transplantation except CNTF. NSC trans-
plantation with SP significantly promoted the expression of
BDNF compared with NSC treatment alone. Expression of all
of the neurotrophin in the group of NSC in DSP, including
BDNF, CNTF, and IGF-1, was much higher than that in DSP
group and NSC + SP group (Fig. 9a–c). Aβ injection could
obviously trigger the upregulation of pro-inflammatory cyto-
kines TNF-α and IL-1β, whereas the downregulation of anti-
inflammatory cytokine IL-10. NSC transplantation could at-
tenuate this phenomenon with significant difference. Samples
from NSC transplantation in SP had a lower level of TNF-α
and higher level of IL-10 than that from NSC transplantation
alone. There was no statistically significant difference in IL-
1β between the group of NSC and NSC in SP. Compared with
the group of NSC transplantation with SP, NSC transplanta-
tion with DSP developed a much higher expression of IL-10
and lower expression of IL-1β. However, no significant dif-
ference was observed in the expression of TNF-α between the
group of NSC + SP and NSC + DSP (Fig. 9d–f). NSC
Fig. 7 NSC transplantation in
DSP was benefit to the recovery
of synaptic function. a
Immunohistochemical analysis of
synapsin-1 in CA1 region. Scale
bar 10 μm. b Expression of
synapsin-1 was detected by
western blot. c The signals of
synapsin-1 were normalized
using GAPDH. *P<0.01 versus
control, #P<0.05 versus NSC +
SP, $P<0.01 versus DSP,
&P<0.01 versus NSC, black
triangle P<0.05 versus SP
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transplantation in DSP also increased the protein level of
BDNF, CNTF, and IL-10 compared to the groups of DSP
and NSC + SP, while it decreased the expression of IL-1β
(Supplementary Table 1).
Discussion
Stem cells with the potential to form many different cell types
are being actively investigated for their potential to replace
damaged or dead cells after injury [32]. However, the efficacy
of the procedure remains hampered by a low rate of sustained
cell engraftment and differentiation toward neurons [16]. In
order to enhance the therapeutic efficacy, many studies have
reported benefits from biomaterials to provide a suitable scaf-
fold for transplanted stem cells. Specifically, self-assembling
peptides that can form 3D structures of nanofibers without
apparent immune response have been developed. These pep-
tides are promising biomaterials for spinal cord repair as they
can easily be injected into the lesion site and can provide
physical support to regrowing nervous tissue [33]. Recently,
lots of bioactive motifs identified from extracellular matrix
Fig. 8 Inhibitory effect of NSC
transplantation in DSP on Aβ1–40
in the brain of AD rats. Aβ1–40
level in rat hippocampus tissue (a)
and cortex (b) was measured by
ELISA. *P<0.01 versus control,
#P<0.05 versus NSC + SP,
$P<0.01 versus DSP
Fig. 9 Determination of neurotrophin and inflammatory cytokine RNA
levels after NSC transplantation. Quantitative real-time PCR of mRNA
expression of neurotrophin (a–c) and inflammatory cytokines (d–f) in
each group at 4 weeks after transplantation. *P<0.05 and **P<0.01
versus control, #P<0.05 and ##P<0.01 versus NSC + SP, $P<0.01 versus
DSP, &P<0.05 and &&P<0.01 versus NSC
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proteins, have been directly coupled on to the self-assembling
peptide to create a more advantageous microenvironment
niche to the survival and differentiation of the stem cells.
But to date, there was no report about the application of stem
cell transplantation with designer self-assembling peptide for
the treatment of AD.
In this study, we firstly utilized the designer peptide with
bioactive motif YIGSR to facilitate the survival and neuronal
differentiation of NSC after being transplanted into the hostile
microenvironment in hippocampus tissue. YIGSR, one of the
laminin-derived bioactive peptides, had similar effect to lam-
inin on the migration and differentiation of neural stem/
precursor cells (NSPCs), thus suggesting biomaterials modi-
fied with YIGSR maybe a potential approach to improve mi-
gration, survival, and neuronal differentiation of stem cells for
neural tissue engineering applications [26]. In our study, a
single infusion of Aβ1–40 effectively impaired learning and
memory behavior, which was consistent with other reports
[34, 35]. Although these rat models do not reproduce the full
complexity of the human disease, they do display a neurode-
generative process and local microglial activation—both usu-
ally absent in transgenic mice models of AD [36]. Compared
to Aβ injection rats, rats receiving NSC showed reduced la-
tency in finding the hidden platform, spatial learning acquisi-
tion. The data confirmed that NSC transplantation is able to
reduce the impairment of spatial memory associated with the
accumulation of Aβ peptide. Compared with the NSC group,
NSC transplantation in SP could decrease the escape latency
significantly after 3 days training. But in the spatial probe
trials, no apparent difference was observed between NSC
and NSC in SP groups. However, rats in the group of NSC
transplantation in DSP had a much shorter latency and
remained in the original platform quadrant longer and crossed
the former platform contained quadrant more frequently com-
pared to NSC carried in SP-treated rats. All of these data
suggested that NSC injection in DSP exerted a much more
efficient improvement of behavior function after Aβ injection.
The main goal of this study was to increase the survival and
neuronal differentiation of NSC. We first investigated the tox-
icity effect of Aβ on NSC in vitro, and the data indicated that
DSP could not only benefit the viability of NSC in normal
culture condition but also suppress effectively the necrosis and
apoptosis induced by Aβ. These results provided a direct hint
to support the hypothesis that survival of grafted NSC was
hampered in vivo. From our study, DSP indeed could increase
the survival of NSC after transplanting according to the ex-
pression of SRY. It has been found that IKVAV-functionalized
self-assembling peptide matrix could favor neuronal differen-
tiation of embryonic stem cells [37]. In our study, there were
more survived cells after transplantation with DSP co-
expressing the neuron marker Tuj-1 than that in the group of
NSC in SP. Neuronal differentiation was facilitated through
YIGSRmodification of RADA16was also confirmed in vitro,
evidence by NSC showed remarkably neuronal differentiation
after seeded in DSP and the cells expressed much more
neuron-related genes including Tuj-1 and NSE than that cul-
tured in SP. These data demonstrated that neuronal differenti-
ation of transplanted NSC may be facilitated through the ad-
dition of YIGSR to RADA16. On the other hand, the adhesion
and interaction between NSC and DSP, which may enhance
the secretion of neurotrophic factors, could also partly inter-
pret this benefit. A recent study found that bioactive motif-
functionalized self-assembling peptides may constitute prom-
ising biomimetic scaffolds for in vitro NSC differentiation, as
well as regenerative therapy of the acute contusive spinal cord
injury in rats [38]. In AD mouse models, it has been reported
that impaired capacity for hippocampal neuron replacement
may contribute to the cognitive decline [39]. Therefore, it is
valuable to utilize the functional motif-modified self-assem-
bling peptides to optimize the survival and neuronal differen-
tiation of NSC according to our and other studies. However,
we didn’t investigate the function of the neurons differentiated
from NSC, although DSP was facilitated to the neuronal dif-
ferentiation. To test whether neurons differentiated from NSC
have functional activity, sodium currents, potassium currents,
action potentials, and synaptic events could be recorded and
analysed with electrophysiological technique. The function of
the neurons differentiated fromNSCwas worth to be explored
and clarified in the future research.
Neuronal loss and synaptic degeneration is the ultimate
event and the main cause of irreversible progression of neuro-
degenerative disorders [34, 40]. Reducing the level of apopto-
sis of hippocampal neurons in acute AD would be the key
strategy to restore the learning and remembering function. It
is well established that the oligomeric forms of the peptide are
neurotoxic as well as synapse toxic [41]. In the present study,
we found that after injection of Aβ, many cells in CA1 regions
demonstrated obvious apoptotic morphology. NSC transplan-
tation with or without peptides could decrease the apoptosis in
CA1 regions. The number of apoptotic cells in the group of
NSC inDSPwasmuch less than that in the groups of NSC and
NSC in SP. Previous studies demonstrated that caspase 3 ac-
tivation is one of the main pathways involved in Aβ-induced
cell death and caspase inhibitors could prevent Aβ-induced
apoptosis in rats [42]. The PI3K/Akt signaling pathway is a
classic anti-apoptosis signal transduction pathway in the cells.
We found that NSC transplantation in DSP prevented the neu-
ronal apoptosis induced by Aβ in hippocampus tissue through
the PI3K/Akt signaling pathway in a caspase-3-dependent
manner.
Reduction in the number of synapses has been reported in
normal aging human subjects and AD patients [43]. Synaptic
proteins are essential components to maintain normal synaptic
function. Synapsin-1 is one of the pre-synaptic proteins which
regulate neurotransmitter release. Our data showed that NSC
transplantation could alleviate the downregulation of
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synapsin-1 induced by Aβ injection. Although SP was bene-
ficial to the recovery of synapsin-1 expression when injected
along with NSC, NSC transplantation in DSP showed more
preferential expression of synapsin-1 than that in the group of
NSC in SP. More interestingly, the YIGSR-functionalized
peptide DSP exerted much more benefit than SP injection
alone, which was worthy to be investigated further.
Synapsin-1 could control the fraction of synaptic vesicles
available for release through changing its state of phosphory-
lation [44]. However, other proteins related to the synaptic
function, such as synaptophysin and PSD95, need to be fur-
ther examined.
Accumulation of deposits of Aβ is thought to be responsi-
ble for neuronal and synaptic loss, leading to progressive cog-
nitive deficits seen in AD. Aβ can interact with various cellu-
lar components to trigger signal transduction cascades that
prompt caspase activation, inflammatory response, free-
radical generation, and Ca2+ deregulation [45]. Each of these
factors can act independently or in concert to damage neurons
and disturb cognitive processes. We found that the treatment
of NSC transplantation in peptides, but not NSC alone, de-
creased the levels of Aβ1–40 in the hippocampus as demon-
strated by ELISA. More important, the expression of Aβ1–40
in the hippocampus in the group of NSC in DSP was much
lower than that in the group of NSC in SP. The downregula-
tion of Aβ1–40 by NSC transplantation in DSP was not only
helpful to suppress the progress of progression of neurodegen-
eration, reduce the apoptosis and synaptic loss, but also con-
tribute to the survival of NSC.
To better understand the effect of DSP on NSC transplan-
tation, we moved forward to test the expression of inflamma-
tory cytokines and neurotrophic factors to determine whether
the interaction of DSP and NSC enhanced the paracrine ac-
tion. TNF-α and IL-1β as pro-inflammatory cytokines, have
been related to the cognitive decline characteristic of AD and
proposed to be valuable biomarkers for this disorder [46].
Reports demonstrate that inflammatory responses mediated
by Aβ peptides in the brains of AD were significantly elevat-
ed, such as IL-1β and TNF-α, which is believed to mediate
neuronal injury and finally, cognitive decline [47]. IL-10 is a
pleiotropic cytokine and inhibits the synthesis and release of
pro-inflammatory cytokines such as TNF-α and IL-1β, -6, -8,
and -12. We found that NSC transplantation in DSP signifi-
cantly decreased the expression of IL-1β and increased the
expression of IL-10 in hippocampus compared with NSC
transplantation in SP. IL-10 could suppresses caspase-3-
mediated neuronal apoptosis [48]. Moreover, virus-mediated
expression of IL-10 in laterally hemisectioned spinal cords
promotes neuronal survival and improves motor function,
both of which are associated with activation of glycogen syn-
thase kinase 3-β, Akt, and STAT3 [49]. Neurotrophic factors,
such as BDNF, CNTF, and IGF-1, play important regulatory
roles in the development, survival, and maintenance of
specific neuronal populations [10, 11]. Neurological improve-
ment may partly be due to the increase of neurotrophic factors
in hippocampus tissue after NSC transplantation. NSC elevat-
ed hippocampal BDNF, leading to increased synaptic density
and restoring hippocampal-dependent cognition [13].
Interestingly, BDNF, CNTF, and IGF-1 were markedly upreg-
ulated after NSC transplantation in DSP compared with the
group of NSC in SP and the group of DSP. These neurotrophic
factors may protect host cells from secondary damage and
improve cognitive function [50]. Moreover, the recovery of
synaptic and cognitive function, the survival and differentia-
tion of NSC, may also be facilitated by the elevated neuro-
trophic factors.
However, there are some limitations to this study. First, the
pathological changes of AD are very complex, and the Aβ
injection model of AD could not completely reflect the pro-
gressive changes of AD. Thus, the effect of NSC transplanta-
tion in DSP should be estimated in other AD models such as
Aβ injection using osmotic minipump and transgenic mice.
Second, learning and memory function only was tested at
4 weeks after NSC transplantation. Therapeutic efficiency
would be further examined for a prolonged period of time to
make a better foundation to the clinic use.
In summary, we have demonstrated that NSC transplanta-
tion in DSP significantly improved spatial learning and mem-
ory deficits in AD rats. Our findings clearly demonstrated that
NSC transplantation in DSP can improve function via both
direct and bystander-like mechanisms. DSP could directly in-
crease the survival and differentiation of NSC into neurons,
decrease the neuronal apoptosis and synaptic loss, on another
hand, NSC transplantation in DSP also provided a trophic
support to modulate inflammation and facilitate the neuropro-
tection. Our data firstly provide novel evidences that NSC
transplantation with DSP was more efficient to enhance neu-
roprotection, neurogenesis, antineuroinflammatory, and pro-
neurotrophic secretion in an Aβ1–40-infused rat model to im-
prove neuronal survival and differentiation and synaptic re-
covery, thus to prevent memory deficiency. This work pro-
foundly supported the therapeutic potential and clinical use
of NSC with biomaterials in the treatment of AD.
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